European Patent Office Signs Agreement with Gene-IT to Equip Examiners with GenomeQuest Sequence Search Software.Business Editors/Health/Medical Writers BIOWIRE2K PARIS Paris, in Greek mythology Paris or Alexander, in Greek mythology, son of Priam and Hecuba and brother of Hector. Because it was prophesied that he would cause the destruction of Troy, Paris was abandoned on Mt. , and WORCESTER, Mass.--(BUSINESS WIRE)--Feb. 9, 2004 EPO EPO see erythropoietin. EPO Erythropoietin, see there Selects Gene-IT's GenomeQuest(TM) Following Study on the Applicability of Sequence Search Algorithms In computer science, a search algorithm, broadly speaking, is an algorithm that takes a problem as input and returns a solution to the problem, usually after evaluating a number of possible solutions. to Patent Research Gene-IT today announced an agreement with the European Patent Office (EPO) to equip e·quip tr.v. e·quipped, e·quip·ping, e·quips 1. a. To supply with necessities such as tools or provisions. b. their examiners with the company's GenomeQuest(TM) sequence searching software. Fundamental to the EPO's decision to select the GenomeQuest software is its ability to deliver results which make the decision to grant Industrial Property rights easier. Equipped with GenomeQuest's potent array of searching capabilities, EPO examiners will be better able to detect all sequences appearing in prior art. "Biotechnology is a particularly sensitive technical field concerning the Industrial Property rights which can be granted. Our examiners must be able to detect all instances of prior art and our studies have led to the conviction that we can no longer rely on traditional biological search methods alone," said Gerard Giroud, principal director at the EPO. "By giving examiners access to GenomeQuest, we have significantly increased our ability to view the entire landscape of patented sequences, which improves the quality of our examination activities in Biotechnology." The agreement was signed following an EPO study on the applicability of sequence search algorithms to patent sequence searching. Patents claiming sequences are often written to not only include a given sequence, but all sequences that are similar in composition and/or function. IP bioanalysts, taking their cue cue, n a stimulus that determines or may prompt the nature of a person's response. cue Psychology Any sensory stimulus that evokes a learned patterned response. See Conditioning. from biologists, initially relied on homology homology (hōmŏl`əjē), in biology, the correspondence between structures of different species that is attributable to their evolutionary descent from a common ancestor. search tools to identify comparable sequences. However, tools like BLAST, which depend on the setting of parameters and vagaries such as query-sequence/database sizes, can produce different results for the same search. This can introduce uncertainty about Industrial Property rights. Additionally, BLAST has a minimum cut-off cut-off Anesthesiology The point at which elongation of the carbon chain of the 1-alkanol family of anesthetics results in a precipitous drop in the anesthetic potential of these agents–eg, at > 12 carbons in length, there is little anesthetic activity, level that can mean no results for peptide peptide, organic compound composed of amino acids linked together chemically by peptide bonds. The peptide bond always involves a single covalent link between the α-carboxyl (oxygen-bearing carbon) of one amino acid and the amino nitrogen of a second amino acid. , and other fragment (1) In networking, one piece of a data packet that has been broken into smaller pieces in order to accommodate the maximum transmission unit (MTU) size of a network. See IP fragmentation. , searches. By contrast, GenomeQuest's GenePAST, which strictly and deterministically detects the percent identity of one sequence to another, and Fragment Search methods overcome these first-generation IP sequence searching limitations. "The EPO delivers a tremendous service to the global patent community and we are delighted that they have decided to equip their examiners with GenomeQuest," said Jean-Jacques Codani, founder and chief executive office of Gene-IT. "We look forward to working with the EPO to ensure the successful deployment of GenomeQuest." GenomeQuest presents results through a "query-oriented" alignment browser browser Software that allows a computer user to find and view information on the Internet. The first text-based browser for the World Wide Web became available in 1991; Web use expanded rapidly after the release in 1993 of a browser called Mosaic, which used and features communication tools that enable researchers to annotate annotate - annotation and collaborate on search findings. Targeted for installation over the next several weeks, GenomeQuest will be made available to the hundreds of EPO examiners that investigate European and international patent applications. "As the EPO has concluded, effective sequence searching involves not only comprehensive and current databases, but also having the right set of search methods for mining the data," said Ronald Ranauro, General Manager, Gene-IT. "GenomeQuest allows multiple sequence databases to be searched at one time and mines the data most effectively by combining biologically-sensitive and IP-sensitive search methods." Financial terms of the agreement were not disclosed. About Gene-IT Gene-IT provides GenomeQuest(TM), browser-based sequence searching software for intellectual property (IP) bioanalysts and functional investigators. With GenomeQuest, researchers can easily search the entire sequence world to quickly determine the IP and functional landscapes for their sequences of interest. GenomeQuest is powered by Biofacet(TM), the company's ultra high-throughput sequence search engine. Additional information may be found at http://www.gene-it.com. GenomeQuest, GenePAST, and Biofacet are trademarks of Gene-IT. All other trademarks are the property of their respective owners. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion